|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:academic_advisor
|
experts in immunotherapy
|
|
gptkbp:acquisition
|
gptkb:Zy_Versa_Therapeutics
|
|
gptkbp:biotech_industry
|
cancer therapeutics
|
|
gptkbp:biotechnology_sector
|
healthcare
|
|
gptkbp:business_model
|
biopharmaceutical development
|
|
gptkbp:ceo
|
gptkb:Kevin_J._Mc_Cormack
|
|
gptkbp:clinical_trial
|
gptkb:cancer_treatment
Phase 2
specific cancer types
multiple sites
adaptive trial designs
promising outcomes
Phase 1, Phase 2
Phase 1/2 trials
TCR-T cell therapy for cancer
|
|
gptkbp:collaboration
|
biopharmaceutical companies
accelerate drug development
|
|
gptkbp:collaborations
|
biotech firms
|
|
gptkbp:community_engagement
|
patient advocacy groups
|
|
gptkbp:develops
|
T cell receptor (TCR) therapies
|
|
gptkbp:focus
|
gptkb:Cell
|
|
gptkbp:founded
|
gptkb:2015
|
|
gptkbp:funding
|
gptkb:venture_capital
grants and investments
|
|
gptkbp:future_plans
|
expand research initiatives
|
|
gptkbp:headquarters
|
gptkb:Houston,_Texas
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Alaunos Therapeutics
|
|
gptkbp:innovation
|
cell therapy technologies
|
|
gptkbp:instruction_set
|
TCR-T therapies
|
|
gptkbp:investment
|
gptkb:public_company
research and development
institutional investors
|
|
gptkbp:investment_focus
|
cancer therapies
|
|
gptkbp:is_a_platform_for
|
TCR technology
|
|
gptkbp:lead_investors
|
gptkb:Canaan_Partners
|
|
gptkbp:mission
|
improve cancer treatment outcomes
|
|
gptkbp:partnership
|
gptkb:University_of_Texas_MD_Anderson_Cancer_Center
|
|
gptkbp:partnerships
|
academic institutions
|
|
gptkbp:patient_population
|
cancer patients
|
|
gptkbp:publications
|
peer-reviewed journals
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
FDA applications
|
|
gptkbp:research
|
cell-based therapies
|
|
gptkbp:research_areas
|
oncology
personalized medicine
|
|
gptkbp:research_focus
|
immuno-oncology
|
|
gptkbp:stock_symbol
|
TCRT
|
|
gptkbp:strategic_goals
|
expand clinical trials
|
|
gptkbp:targets
|
solid tumors
|
|
gptkbp:team
|
experienced executives
|
|
gptkbp:technology
|
TCR-T cell therapy
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:type_of_care
|
clinical trial participants
|
|
gptkbp:vision
|
transform cancer care
|
|
gptkbp:website
|
www.alaunostherapeutics.com
|
|
gptkbp:bfsParent
|
gptkb:Cure_Vac
|
|
gptkbp:bfsLayer
|
4
|